United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 20, 2026 · Filed Jul 21, 2026

On Jul 20, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$531.69 for US$5.05M under a trading plan, leaving 324,443 shares. Filed Jul 21, 2026 (Form 4).

Sold
9,500 shares
Price
US$531.69 average (US$529.19 to US$536.41)
Value
US$5.05M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 20, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 20, 2026Common StockSale1,831US$529.19332,112Indirect
Jul 20, 2026Common StockSale960US$529.85331,152Indirect
Jul 20, 2026Common StockSale1,660US$531.08329,492Indirect
Jul 20, 2026Common StockSale1,874US$532.07327,618Indirect
Jul 20, 2026Common StockSale1,686US$533.03325,932Indirect
Jul 20, 2026Common StockSale889US$534.13325,043Indirect
Jul 20, 2026Common StockSale520US$535.20324,523Indirect
Jul 20, 2026Common StockSale80US$536.41324,443Indirect

Source

View original at SEC

Related